Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy

被引：11
|
作者：
Copur, Mehmet Sitki [1 ]
Crockett, David [1 ]
Gauchan, Dron [1 ]
Ramaekers, Ryan [1 ]
Mleczko, Kris [2 ]
机构：
[1] CHI Hlth St Francis Canc Treatment Ctr, Grand Isl, NE 68803 USA
[2] CHI Hlth St Francis Med Ctr, Grand Isl, NE USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 19期
关键词：
REARRANGEMENT; ASSOCIATION; PATHOLOGY; COLLEGE;
D O I：
10.1200/JCO.2018.78.8240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2006 / +
页数：2
相关论文
共 50 条
  • [21] Molecular Biomarker Testing and Initiation of Targeted Therapy in Minority Patients with Stage IV Non-small Cell Lung Cancer
    Villanueva, M.
    Brice, K.
    Dumais, K.
    Uribe, C. R. Carracedo
    Nano, O.
    Rodriguez, M.
    Osmon, E.
    Raez, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S452 - S452
  • [22] Guideline Updates on Lung Cancer: Cancer Immunotherapy and molecular Testing are gaining significant Importance
    不详
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (06)
  • [23] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (vol 8, pg 823, 2013)
    Lindeman, N., I
    Cagle, P. T.
    Beasley, M. B.
    Chitale, D. A.
    Dacic, S.
    Giaccone, G.
    Jenkins, R. B.
    Kwiatkowski, D. J.
    Saldivar, J. S.
    Squire, J.
    Thunnissen, E.
    Ladanyi, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (10) : 1343 - 1343
  • [24] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (vol 137, pg 828, 2013)
    Lindeman, N., I
    Cagle, P. T.
    Beasley, M. B.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (06) : 1174 - 1174
  • [25] Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline
    Tung, Nadine
    Ricker, Charite
    Messersmith, Hans
    Balmana, Judith
    Domchek, Susan
    Stoffel, Elena Martinez
    Almhanna, Khaldoun
    Arun, Banu
    Chavarri-Guerra, Yanin
    Cohen, Stephanie A.
    Cragun, Deborah
    Crew, Katherine D.
    Hall, Michael J.
    Idos, Gregory
    Lopez, Ghecemy
    Pal, Tuya
    Pirzadeh-Miller, Sara
    Pritchard, Colin
    Rana, Huma Q.
    Swami, Umang
    Vidal, Gregory A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (21)
  • [26] Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell Lung Cancer and Colorectal Cancer
    Roberts, Thomas J.
    Kehl, Kenneth L.
    Brooks, Gabriel A.
    Sholl, Lynette
    Wright, Alexi A.
    Landrum, Mary Beth
    Keating, Nancy L.
    [J]. JAMA NETWORK OPEN, 2023, 6 (04) : E2310809
  • [27] Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives
    Imyanitov, Evgeny N.
    Iyevleva, Aglaya G.
    Levchenko, Evgeny V.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [28] Engaging Lung Cancer Patients in their Molecular Testing
    Ciupek, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S80 - S80
  • [29] Bone metastasis of lung cancer and its molecular targeted therapy
    Yano, Seiji
    Muguruma, Hiroaki
    Ohtsuka, Shinsaku
    Miki, Toyokazu
    Uehara, Hisanori
    Kawatani, Makoto
    Osada, Hiroyuki
    Sone, Saburo
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (04) : 222 - 222
  • [30] Clinical experiences with molecular targeted therapy in lung cancer in China
    Wang, Yan
    Sun, Yan
    [J]. THORACIC CANCER, 2015, 6 (04) : 379 - 384
12345